2010 / 2011 PHARMACEUTICAL Industry - Bristol

Transcription

2010 / 2011 PHARMACEUTICAL Industry - Bristol
2010 / 2011 Pharmaceutical Industry Fellowship Program
2010 / 2011 Pharmaceutical
Industry Fellowship Program
fostering groWth anD DeVeloPment
1
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 1
10/27/10 9:41 AM
Dear Prospective Fellow,
On behalf of Bristol-Myers Squibb and the Ernest
Mario School of Pharmacy, I would like to thank you
for your interest in the Post-Doctoral Pharmaceutical
Industry Fellowship Program. As you consider your
options following graduation from pharmacy school,
I encourage you to consider the numerous fellowship
opportunities available at Bristol-Myers Squibb.
It is truly an exciting time in the pharmaceutical industry,
and the opportunities available for pharmacists are endless.
At Bristol-Myers Squibb, we are committed to the development
of highly motivated individuals with a track record of achievement.
For more than ten years, we have been devoted to creating a bestin-class fellowship program. As a result, our top-notch fellowship
program has proven itself year after year as a launching point for
a rewarding and successful career in the industry.
At Bristol-Myers Squibb, our reputation for social responsibility
is as important as our reputation for innovative medicines. We
continue to hold ourselves accountable to the highest standards
of integrity and act on our belief that “the priceless ingredient
of every product is the integrity of its maker.” Every year, we
continue to break new ground in our philanthropic efforts.
I take great pride in our work at Bristol-Myers Squibb to help
patients prevail over serious diseases. Our company is truly
focused on creating products that address significant unmet
medical needs and make a real difference in the lives of patients.
If you are the type of person who is truly excited about joining
a company that brings hope to millions of people, I invite you
to consider Bristol-Myers Squibb as your first step into the
pharmaceutical industry.
I wish you the best of luck during the recruitment process and
hope you strongly consider the fellowship opportunities available
at Bristol-Myers Squibb.
Sincerely,
Anthony C. Hooper
Senior Vice President, Commercial Operations,
and President, U.S., Japan and Intercontinental
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 2
10/27/10 9:41 AM
Bristol-myers sQuiBB
Bristol-Myers Squibb is a global biopharmaceutical company firmly focused
on its Mission to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases.
Around the world, our medicines help millions of people in their fight against
cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid
arthritis and psychiatric disorders.
our strategy
At Bristol-Myers Squibb, our BioPharma
strategy uniquely combines the reach and
resources of a major pharma company with
the entrepreneurial spirit and innovation
of a successful biotech company. This
strategy has produced strong results for our
company in recent years – and it positions
us well to address a changing marketplace
and our customers’ evolving needs.
Bristol-Myers Squibb’s R&D organization
is considered among the most productive in
the industry. Since 2002, we have delivered
nine key products for patients in need.
Six of those medications were discovered
internally by Bristol-Myers Squibb
scientists. And our pipeline continues to
expand: In 2009, Bristol-Myers Squibb
increased the number of compounds across
all of its therapeutic areas in Exploratory
and Full Development by nearly 40
percent. About one-third of our compounds
in development are biologics.
In addition, we continue to enhance
our internal capabilities through
strategic partnerships, alliances
and acquisitions – our String of Pearls
strategy. These pearls have been pivotal
to the company’s continued progress
in biologics, targeted small molecules
and other next-generation platforms.
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 1
our resPonsiBility
As a BioPharma leader, integrity is the
foundation from which we work. We
take our responsibilities seriously, and
strive always to do the right thing for the
benefit of the patients and customers we
serve, our employees, our company and our
communities worldwide.
Through our philanthropic organization,
the Bristol-Myers Squibb Foundation,
we seek to bridge gaps in health care and
address health disparities. Our Foundation
focuses on community-based programs
to fight HIV/AIDS in Africa, hepatitis in
Asia, type 2 diabetes and serious mental
illness in the U.S., and cancer in central
and eastern Europe.
The model for these programs is
Bristol-Myers Squibb’s groundbreaking
SECURE THE FUTURE®. This $150
million program, established in 1999 to
help confront HIV/AIDS in Africa, has
funded more than 240 projects in 20
African countries, integrating clinic-based
medical care with community-based health
education and supportive care.
Preservation of our natural resources also
represents one of our key commitments.
At many of our facilities worldwide,
our company is integrating comprehensive
energy management, pollution controls and
other practices to reduce environmental
impacts. Since 2000, the company has
met and surpassed the majority of its
sustainability goals, including a 40 percent
reduction in energy use, normalized to
sales. Bristol-Myers Squibb was ranked
eighth among 500 of the largest U.S.
corporations in Newsweek’s 2009
Green Ranking.
Bristol-Myers Squibb is also a great place
to work. We are committed to a diverse
workforce and an inclusive culture. We
are also committed to recruiting, retaining
and developing top talent. We provide
employees with many opportunities for
career development and advancement,
and our performance management system
rewards behaviors as well as results.
Bristol-Myers Squibb has been recognized
year after year as one of the best companies
for women, female executives and working
parents. We’ve also been recognized by
the Human Rights Campaign Foundation’s
Corporate Equality Index for achieving a
perfect score for the past four consecutive
years.
Bristol-Myers Squibb delivers on its
commitments: to our patients and
customers, to our employees, to our global
communities, to our shareholders and to
the environment.
1
10/27/10 9:41 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
Program history
JosePh a. Barone, Pharm.D., f.c.c.P.
Professor and Chairman, Pharmacy
Practice and Administration
In 1984, at Rutgers, The State University of New Jersey, the Ernest Mario School of
Pharmacy and two pharmaceutical companies began a collaborative pilot program
to evaluate the potential contributions of clinically-trained pharmacists within a
pharmaceutical industry practice setting. Following the successful pilot, the Rutgers
Pharmaceutical Industry Fellowship (RPIF) Program grew significantly and expanded
to include 12 companies within the pharmaceutical and biopharmaceutical industries
and almost 90 Fellows annually. The RPIF Program has thrived under the leadership of
the founder, Dr. Joseph A. Barone, Chair of the Department of Pharmacy Practice and
Administration and Dr. James G. Alexander, a Fellowship alumnus and now the Director
of the Institute for Pharmaceutical Industry Fellowships.
In 2002, Dr. Ernest Mario generously provided an endowment to establish the Institute
for Pharmaceutical Industry Fellowships to enhance and promote the role of
pharmacists in industry through the RPIF Program. The Institute staff members:
• provide leadership and administrative support;
• promote quality, communication, and scholarly activity; and
• arrange specialized Fellowship training opportunities within the pharmaceutical and
biopharmaceutical industries.
James g. alexanDer, Pharm.D.
More than 500 post-doctoral Fellows have completed the RPIF Program, most of
whom are pursuing influential and rewarding careers in the pharmaceutical and
biopharmaceutical industries throughout the US and abroad. The RPIF Program has
preceptors/mentors from the industry who share their knowledge and experiences with
the Fellows through an intense but closely-guided training program. Assignments and
projects are challenging, meaningful, and designed to enhance understanding of the
pharmaceutical and biopharmaceutical industries and the Fellow’s functional area.
Rutgers, The State University of New Jersey, with approximately 54,000 students in its three
campuses, is one of the major state university systems in the United States. The New Jersey
College of Pharmacy was founded in 1892 and was incorporated into the University in 1927.
The Ernest Mario School of Pharmacy is the only school of pharmacy in New Jersey, with
approximately 1,400 students in its Doctor of Pharmacy program.
The Rutgers Ernest Mario School of Pharmacy is located on the University’s main science
and technology campus in Piscataway, New Jersey. Because of its close proximity to the
nation’s leading pharmaceutical and biopharmaceutical companies, the Ernest Mario School
of Pharmacy and the RPIF Program are uniquely capable of providing Fellows with exposure
to the pharmaceutical and biopharmaceutical industries.
2
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 2
10/27/10 9:41 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
Bristol-myers sQuiBB comPonent
rutgers comPonent
Bristol-Myers Squibb and Rutgers, the State
University of New Jersey, Ernest Mario
School of Pharmacy are collaborating
to offer post-Pharm.D. fellowships in:
Medical Education, Medical Information,
Medical Science Liaison, Medical Strategy,
Scientific Communications, R&D Strategy
and Analytics, Advertising and Promotion
Regulations, Global and US Medical
Affairs, and Health Policy and Advocacy.
The Fellows will become an integral part
of their respective teams and will be trained
to manage a broad range of responsibilities,
similar to those managed by current team
members. This fellowship program will
necessitate interaction and teamwork with
departments in all aspects of the corporation,
such as Global Pharmacovigilance and
Labeling, Sales, Medical Strategy, Marketing,
Regulatory Services, Legal, Clinical Trials,
Post-Marketing Clinical Research, and
Health Care Channel Management.
A significant majority of the fellowship
experience is spent at the participating
company, gaining industry experience.
Fellows are appointed as Rutgers adjunct
faculty, providing opportunities in the
academic component of the program.
These include teaching or precepting
pharmacy students, as well as poster,
publication and research opportunities.
While at Bristol-Myers Squibb, the Fellows
will participate in various team-building
activities and attend leadership development
lectures with senior management. The
Fellows will also have opportunities to
participate in a mentorship program with
senior management and fellowship alumni, to
lead and take part in fellowship committees,
and to attend Lunch and Learn meetings.
Bristol-Myers Squibb is committed to
providing its Fellows with opportunities
to develop networks and gain exposure to
new perspectives throughout the company.
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 3
Professional
DeVeloPment series
All Fellows gather at Rutgers once or
twice monthly as a group to participate in
the Professional Development Day (PDD)
Series, an important component of their
training that complements the handson experience provided at the partner
companies. The PDDs are steered by a
committee of Fellows and are designed to
enhance the Fellows’ presentation skills,
promote connectivity and a sense of
community among Fellows from different
companies and disciplines, develop new
skill sets under the guidance of external
trainers, and provide general knowledge
about various aspects of drug development
and issues facing the pharmaceutical and
biopharmaceutical industries.
The Fellows learn from each other through
individual and group presentations
on topics and issues related to the
pharmaceutical and biopharmaceutical
industries. This dynamic forum provides
an opportunity for open discussion and
debate among Fellows, Rutgers faculty
and company preceptors. In addition,
outside experts provide training and
professional development in a variety of
areas (e.g., tools for corporate success;
professional writing, presentation,
negotiating, influencing, networking,
and conflict resolution skills; giving
and receiving feedback; and business
and dining etiquette). Other PDD guest
speakers include industry executives and
successful RPIF Program alumni who
share their insights and experiences.
Importantly, PDDs provide an excellent
opportunity for Fellows to interact with
each other and develop lasting personal
friendships and a strong professional
network of Fellows, faculty, alumni and
other industry executives.
3
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
testimonials
learn from the exPeriences of colleagues
“ The Bristol-Myers Squibb Fellowship
program has provided me with a solid
foundation in Medical Information.
The experiences I gained as a Fellow
prepared me for a successful career in
the pharmaceutical industry and in my
current role. As a Fellow, I was an integral
part of my team and was afforded various
opportunities. My preceptors and mentors
were truly invested in my career growth
and development. The experiences and
friendships I have gained throughout my
Fellowship and current role are invaluable
and will last me a lifetime. The program
provides you with the necessary tools and
opportunities you need to lead you on a
path towards a rewarding career.”
Priya Darouian, Pharm.D.
Associate Director,
Medical Information Center
Fellow—2003–2004
“ There are tremendous opportunities for
pharmacists here at Bristol-Myers Squibb
in all phases of the business. In our
company there is a strong emphasis on
the development of people, leadership,
and gaining cross-functional experiences.
In my own development I have held
positions in sales, sales management,
and medical operations. At Bristol-Myers
Squibb you are only limited by your own
desires and performance.”
James Prazak, r.Ph.
Director, Bristol-Myers Squibb Patient
Assistance Center of Excellence
“ The Fellowship is not only the best bridge to industry experience and career
opportunities out there for PharmD graduates, it is also a ton of fun and a tremendous
experience to make so many new friends and business relationships. As a Fellow
I gained the experiences needed to launch a career in the pharmaceutical industry
and I am very grateful to those like Joseph Barone and Jim Alexander who started
this program. I can’t say enough about how glad I am that I chose to sign up for this
program when the offer was extended.”
JosePh Brougham, Pharm.D.
Medical Science Liaison
Fellow—2002–2003
“ The Rutgers Post-Doctoral Fellowship at Bristol-Myers Squibb has helped me build
a solid foundation in medical information. My preceptors and mentors have trained
me in all the core functions of medical information, while also involving me in
various projects to further enhance my skill set. The Fellowship has helped me to
further develop a strong sense of responsibility, effective interpersonal skills, and
the ability to contribute as an active member in a team setting. My experience has
far exceeded my expectations, with the unwavering support from current and past
Fellows within the organization. I have been very fortunate that this opportunity has
helped me prepare for my current role as Manager, Medical Information Contact
Center, and to continue working in the same department in which I completed my
Fellowship.”
lisa Patel, Pharm.D.
Manager, Medical Information
Fellow—2008–2009
“ The Rutgers Post-Doctoral Fellowship at Bristol-Myers Squibb gave me the
opportunity to build a strong foundation for my career in the pharmaceutical industry.
I had some previous experience with other pharmaceutical companies, but the
Fellowship afforded me the opportunity to fully experience a Medical Information
group in a competitive environment. I put a lot of effort into my Fellowship, but my
return was much greater. I’ve continued to stay connected to the Fellowship Program,
and enjoy this ongoing commitment. I continue to learn from the Program as my
career progresses.”
carolyn seyss, Pharm.D.
Director, Promotion Compliance
Fellow—1994–1995
4
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 4
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
felloWshiPs
offereD
r&D strategy anD analytics–1-year felloWshiP
The R&D Strategy and Analytics group in the Bristol-Myers Squibb Research and
Development organization utilizes clinical, scientific and commercial expertise in
providing assessments and analyses that enable strategy development and decision
making. Each Fellow is provided with the opportunity to understand the workings
of the pharmaceutical R&D process as well as the understanding of competitive issues
faced by a major R&D organization. Key activities would be:
BernarD lee, Pharm.D.
R&D Strategy and Analytics Fellow
■
Develop high-quality competitive assessments including ongoing monitoring
of key competitors’ R&D activities and pipelines.
■
Develop analyses and assessments in support of R&D strategy development
or strategic decisions.
■
Participate in efforts to provide competitive intelligence focused on competition
to Bristol-Myers Squibb pipeline molecules.
■
Participate in ongoing efforts to identify and evaluate Business Development
and Licensing opportunities through competitive, technical and market analysis.
■
Support department management with key projects to address near-term
operational and strategic issues.
aDVertising anD Promotion regulations–
1-year felloWshiP
sheena Patel, Pharm.D.
Advertising and Promotion
Regulations Fellow
Massachusetts College of Pharmacy
and Health Sciences
The Promotion Compliance group at Bristol-Myers Squibb provides expert and
strategic guidance on advertising and promotion regulations within the company. The
regulatory advice provided by this group assists the marketing organization in ensuring
that effective product advertising and promotion are consistent with federal regulations
and company policies. The group collaborates with a variety of functions including
Marketing, Medical Affairs, Global Regulatory Sciences, Global Labeling, Managed
Markets and Legal. During the 1-year fellowship, the Advertising and Promotion
Regulations Fellow will be assigned to a primary therapeutic area. Key activities and
learnings for the Post-Doctoral Fellow will include:
■
Gain an understanding of key federal regulations and Bristol-Myers Squibb policies.
■
Assess proposed promotional materials and programs created by Marketing, Sales or
Corporate Affairs to promote or publicize approved Bristol-Myers Squibb products to
professional and consumer audiences.
■
Collaborate with matrix team members to identify solutions that meet regulatory
requirements as well as commercial objectives.
■
Analyze the impact of FDA Division of Drug Marketing, Advertising and
Communications enforcement actions and assess the regulatory implication to
commercial activities.
5
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 5
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
meDical eDucation, giVing anD assistance (mega)–
1-year felloWshiP
During this unique 1-year fellowship, the Fellow
will gain exposure to and an understanding of
Bristol-Myers Squibb Standard Operation Procedures
and Processes for Independent Medical Education
(IME), Charitable Giving and Patient Assistance
Center for Excellence. The Fellow’s primary
responsibilities will be with the Independent Medical
Education team in designated disease area(s) of focus.
Key activities and learnings for the Fellow will include:
■ Develop an understanding of the internal and
external regulatory and legal environments that
impact MEGA activities.
■ Create and lead the IME educational needs
assessment for designated disease area(s)
of focus (strategy development).
■ Apply IME needs assessment learnings to
development of related Charitable Giving
strategy and Patient Assistance program(s).
■ Develop an assessment of current IME landscape
across the pharmaceutical industry.
■ Acquire therapeutic expertise in designated
disease area(s) of focus.
■ Perform medical review and analysis of IME grant
proposals and provide recommendations to Grant
Review Committee.
■ Perform program outcomes review and analysis
of educational effectiveness and impact for select
IME programs.
■ Demonstrate proficiency in working within
and across various internal and external
customer interfaces.
amanDa scofielD, Pharm.D.
Medical Education, Giving and
Assistance (MEGA) Fellow
Rutgers University
“
BMS offers tremendous opportunity
for pharmacists. I joined BMS because of
those diverse development experiences:
the breadth of options from Oncology to
Infectious Disease to helping patients and
consumers who have diabetes.
Bringing good medicines to patients is why I
chose this profession. I am able to realize that
through my work at BMS.
Jill m. DEsimone, r.Ph.
Senior Vice President, Oncology
I started in sales and have never looked
back … and have used my pharmacy
background in all the positions in Sales
and Marketing which I have held.
”
6
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 6
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
meDical information: carDioVascular / metaBolics–
1-year felloWshiP
arPit ganDhi, Pharm.D.
Medical Information: CV/Metabolics Fellow
Rutgers University
The Medical Information department is responsible for providing medical and scientific
knowledge on all Bristol-Myers Squibb pharmaceutical products. As part of this program,
Fellows will gain numerous development opportunities by:
■ Developing fair and scientifically balanced information to appropriately respond
to unsolicited medical inquiries related to medical discoveries, clinical trials
and/or clinical practice.
■ Enhancing medical writing skills to maintain a comprehensive product response database,
as well as a compendium of key product data for managed care, hospital and Medicaid
formulary committees.
■ Improving verbal communication skills for dissemination of comprehensible product
information to all levels of educational backgrounds.
■ Participating in the medical review of promotional and non-promotional materials with
matrix team members (e.g., Marketing, Legal and Regulatory).
■ Interacting with Medical Science Liaisons to identify key product issues and unmet
medical needs.
■ Representing Bristol-Myers Squibb in product medical information booths at national
medical and professional conferences.
meDical strategy: carDioVascular–1-year felloWshiP
This 1-year fellowship provides an opportunity to learn and understand the role of Medical
Strategy. The Medical Strategy department at Bristol-Myers Squibb works in conjunction
with various departments (e.g., Marketing, Sales, Legal and Regulatory) by providing medical
expertise based on unmet medical needs of patients and providers within the marketplace.
The Medical Strategy role allows the Fellow to utilize his/her clinical therapeutic knowledge
while gaining an understanding of the business dynamics of the pharmaceutical industry.
Every Fellow’s experience is unique and based on a combination of personal goals and
department needs. The Fellow will support the following functions:
roshni Patel, Pharm.D.
Medical Strategy: Cardiovascular Fellow
Rutgers University
■
Participate in medical matrix team to support strategic planning based on unmet
medical need.
■
Support the execution of the Medical Strategy tactical plan by working among
cross-functional teams and with joint venture partners.
■
Develop medical training materials for Sales Representatives and deliver medical
presentations at sales training sessions.
■
Lead the execution of National and International Congress planning activities to help
shape the Medical Plan.
7
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 7
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
Virology meDical information / meDical strategy–
2-year felloWshiP
This 2-year fellowship provides a unique experience for individuals interested in
developing their clinical and product expertise and medical communication skills
within a matrix environment. The Fellow will collaborate with internal stakeholders,
including Research and Development, Marketing, Legal and Regulatory, as well as
interact with health care providers. The Fellow will support the development and
execution of US Medical Strategy activities to address unmet medical needs of
patients and providers by:
anJali guPta, Pharm.D.
Medical Strategy: Virology Fellow
University of the Sciences in Philadelphia
Jonathan horVath, Pharm.D.
Medical Information: Virology Fellow
Long Island University
■
Developing and communicating HIV disease state and product information to
health care providers.
■
Developing and providing fair and scientifically balanced responses to unsolicited
medical inquiries, while working within advanced information systems.
■
Providing strategic medical support for advisory board content, promotional materials,
and Medical Science Liaison (MSL) resources and training.
■
Participating in the medical review of promotional and non-promotional materials in
collaboration with Legal, Regulatory and Marketing teams.
■
Developing and delivering medical training for Field Medical and Sales Representatives.
■
Driving the Bristol-Myers Squibb MD Fellows Research Training Program to support
new physicians in clinical research by tracking applications, coordinating internal
reviews and working with MD Fellows to initiate their projects.
■
Assisting in the development and implementation of strategic post-marketing
clinical trials.
■
Providing assessment and interpretation of clinical study results and supporting
development of publication plans.
gloBal anD us scientific communications / meDical strategy:
carDioVascular / metaBolics–2-year felloWshiP
claire tsai, Pharm.D.
Scientific Communications/Medical
Strategy: CV/Metabolics Fellow
This distinctive 2-year fellowship provides an
opportunity to experience the role of Medical/
Scientific Communications from both a US
and Global perspective. The Fellow will gain
direct, hands-on experience working with
both internal and external stakeholders in the
development and execution of publication
plans and role out of key scientific content
for investigational and/or marketed products.
The fellowship will provide the Fellow with
a broad foundation for their future career in
the pharmaceutical industry. The Fellow will
support the following key activities:
meDical communications
hQ (gloBal)
■
8
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 8
Establish the scientific foundation for
designated investigational products
through the development and execution
of global publication and scientific
communication plans.
■
Develop core medical materials for key
scientific data releases.
■
Execute company sponsored medical
education at international congresses.
us scientific communications/
meDical strategy
■
Based on the global plan, construct medical
communication strategies in order to ensure
consistency in communications across all
matrix functions within the Cardiovascular/
Metabolics portfolio.
■
Develop publication strategies and execute
the overall publication plan.
■
Execute the Medical Strategy tactical plan by
working cross-functionally in a matrix team.
■
Develop medical training materials for
Sales Representatives and deliver medical
presentations at sales training sessions.
10/27/10 9:42 AM
o
y:
2010 / 2011 Pharmaceutical Industry Fellowship Program
meDical science liaison / meDical information–
2-year felloWshiP
anuJ Patel, Pharm.D.
Medical Science Liaison/Medical
Information First-Year Fellow
toDD okamoto, Pharm.D.
Medical Science Liaison/Medical
Information Second-Year Fellow
University of Southern California
The Medical Science Liaison (MSL)/
Medical Information Fellowship position
will provide a novel 2-year experience for
individuals interested in developing core
competencies in Medical Science Liaison
and Medical Information roles. Fellows will
obtain product and therapeutic expertise
in a therapeutic franchise to disseminate
information through in-house and field-based
interactions with medical professionals across
health care sectors. Through daily activities
and special projects, individuals will develop
an understanding of the business environment
and associated federal and corporate
regulations, comprehend how Medical Affairs
professionals work in cross-functional teams,
obtain project planning and leadership skills,
learn how to conduct a research project, and
build mentoring skills. Key activities will
include:
■ Participate in field-related MSL activities.
■ Develop MSL training materials and
reactive slide decks.
■ Co-lead planning for participation at
Medical Congresses.
■ Co-facilitate sales training sessions.
Provide support for managed markets.
Participate in speaker program processes.
■ Attend MSL medical presentations to health
care professionals.
■ Become involved in internal and external
clinical trial operations.
■ Collaborate with matrix teams to develop
and execute medical strategy.
■ Participate in an integrated global medical
services organization focused on customercentric, immediate medical information
delivery utilizing state-of-the-art
technology.
■ Engage in educational training sessions.
■ Build verbal communication skills
as a therapeutic expert in the
Medical-On-Call model.
■ Conduct medical intelligence analysis.
■ Prepare responses for global database.
■ Assist with medical review for promotional
and non-promotional materials.
■ Mentor Pharm.D. students rotating through
MI and MSL departments.
■ Conduct research to be presented at a
national, professional meeting.
■
■
oncology gloBal meDical / us meDical strategy–2-year felloWshiP
This 2-year fellowship will provide the
Fellow a unique opportunity to develop
experience in a strategic medical role,
supporting development and execution of
Global Medical strategy to ensure safe and
appropriate use of Bristol-Myers Squibb
oncology products. The fellowship will
provide opportunity for development of
leadership skills through collaboration
across Global and US Medical matrix teams
and other key partners (e.g., Marketing,
Market Access, Global Clinical Research,
Scientific Communications and Field
Medical Science).
The Oncology therapeutic area provides
unique challenges for key medical
interactions and input across multiple
indications within one product (granting
depth and breadth of knowledge) as well
as the opportunity for exposure to different
pipeline compounds.
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 9
gloBal meDical (2011-2012)
■ Support development and execution
of Global Medical Plan.
■ Support development of global
advisory boards to gain insight
into how different tumor types
are treated across the globe.
■ Support the development of the
Scientific Communication Platform.
■ Support the generation of data to
ensure the safe and appropriate
use of Bristol-Myers Squibb
oncology products.
■ Actively participate in the Medical
Strategy and Communication (MSC)
team and partner with medical
colleagues in the regions, including
Clinical, Discovery, Regulatory,
Commercial, Access, Health
Outcomes and other key functions.
us meDical strategy (2012-2013)
■ Provide scientific and execution
support to the US Medical Strategy
team while working on an integrated
matrix team with both Medical and
Marketing colleagues.
■ Support planning and execution of
key medical initiatives including:
■ Medical advisory boards and/or
investigator meetings.
■ Development of Field Medical
Science resources.
■ Medical matrix training.
■ Speaker training.
■ Congress/conference planning
and support, content development
for medical presentations, and
publication support.
■ Provide medical input on educational
and promotional materials.
9
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical Industry Fellowship Program
oncology meDical affairs: meDical science liaison /
meDical information / clinical trials–2-year felloWshiP
This 2-year fellowship provides an opportunity to develop an understanding of the functional
areas of Medical Science Liaison (MSL), Medical Information and Clinical Trial Operations.
Fellows will acquire oncology disease state knowledge and master data regarding oncology
product portfolio and corresponding competitors through these various roles. Fellows will
also collaborate and network with cross-functional teams (e.g., Legal/Regulatory, Marketing,
Medical Strategy). During the 2nd-year, Fellows will gain enhanced experiences through
elective rotations in other departments and leadership of special projects.
Jose argueta, Pharm.D.
Oncology Medical Affairs First-Year Fellow
Rutgers University
meDical science liaison:
■
Shadow MSLs on a monthly basis and participate in interactions with Health Care
Professionals.
■
Participate in weekly MSL training.
■
Support promotional speaker programs through speaker training and program attendance.
■
Attend educational meetings (COOP, CME, or MSL training).
■
Support ongoing clinical trials through protocol reviews, site initiation visits, site education
and quarterly visits.
■
Assist with headquarters-based field medical projects.
meDical information:
iram ahmaD, Pharm.D.
Oncology Medical Affairs
Second-Year Fellow
University of Illinois at Chicago
■
Function as a Medical Information specialist by applying clinical pharmacy knowledge
to ensure accurate communication of Bristol-Myers Squibb product information.
■
Enhance medical writing skills by developing fair and scientifically-balanced responses
to medical inquiries.
■
Participate in medical review of promotional and disease-related materials.
■
Interact with cross-functional promotion review team members (e.g., Marketing, Legal
and Promotion Compliance).
■
Represent Bristol-Myers Squibb at key national meetings and answer medical
inquiries onsite.
clinical trial oPerations:
■
Function as a Clinical Trial Manager of Investigator-Sponsored Trials, which includes
study activation and leading them through various stages of development (e.g., protocol
development, investigator selection, budget negotiation and drug supply provision).
■
Gain a working knowledge of the different trial types (Investigator-Sponsored Trials,
Cooperative Groups, Networks, and company-sponsored trials).
■
Assist in the preparation of key medical and investigator meetings.
■
Participate in protocol review meetings.
■
Interact with MSLs in trial management and interface with investigators on an
ongoing basis.
10
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 10
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical
neuroscience gloBal meDical–2-year felloWshiP
This 2-year fellowship experience provides an opportunity to learn and understand three
functional areas with broad application of clinical skills within a BioPharma environment.
The Fellow will support key activities in the following areas:
meDical strategy:
Participate in data generation to answer questions related to unmet medical needs.
■
amy eVeritt, Pharm.D.
Neuroscience Global Medical Fellow
Nova Southeastern University
■
Lead data dissemination efforts to internal and external stakeholders, and the wider
medical community via abstracts and poster development for scientific congresses and
peer-reviewed medical publications.
■
Participation in cross-functional activities with Field Medical, Marketing, Collaborative
Science, Medical Information and Medical Education is encouraged.
meDical information:
Respond to unsolicited medical inquiries from health care professionals.
■
■
Participate in medical review of promotional and non-promotional materials with matrix
team members (Marketing, Regulatory and Legal).
■
Participate in maintaining product response database by developing or updating product
summaries, AMCP Dossier, and Formulary Kits.
■
Lead the generation and analysis of metrics and inquiry trends.
gloBal scientific PuBlications:
Collaborate with internal and external authors to develop high-quality scientific
publications (e.g., manuscripts, abstracts, posters, oral presentations) to support the clear
scientific communication of Bristol-Myers Squibb products at both the US and HQ level.
■
■
Monitor evolving external publication landscape, distill best practices and drive process
improvements to establish Bristol-Myers Squibb as an industry leader with respect to
ethical, quality, and timely publication production.
■
Contribute to the development of the Scientific & Medical strategic communication
platform and oversee execution to support scientific exchange of key data.
Policy anD aDVocacy–2-year felloWshiP*
health Policy:
mina alsaraf, Pharm.D.
Policy and Advocacy Fellow
■
Research public policy issues.
■
Help develop policy positions.
■
Support Evidence-Based-Medicine
Policy Issue.
■
Evaluate State & Federal Health
Care Reform proposals and draft
related policy positions.
aDVocacy:
■
Evaluate opportunities that are unique
to establishing strategic alliances with
health care quality, professional and
patient organizations that focus on
diabetes or cardiovascular disease.
■
Interact with health care professional,
patient and quality organizations.
■
Apply, integrate, and communicate
real world data sources into customer
model in cooperation with Health
Outcomes team.
■
Develop an appreciation and understanding
of how public policy issues impact the
health care business environment.
■
Interact with key external organizations
involved in policy development.
■
Collaborate across matrix team to
develop and execute policy and
advocacy initiatives.
Conduct ongoing assessment of the
evolving health care quality environment.
■
Participate in charitable giving reviews.
■
*This fellowship is offered once every two years and will recruit next for the 2012-2014 position.
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 11
11
10/27/10 9:42 AM
2010-2011 felloWs
Sitting: Todd Okamoto, Arpit Gandhi
First Row: Anuj Patel, Mina Alsaraf, Jonathan Horvath, Amanda Scofield, Bernard Lee, Anjali Gupta, Jose Argueta
Standing: Iram Ahmad, Sheena Patel, Amy Everitt, Roshni Patel, Claire Tsai
2010-2011 PrecePtors
12
Front Row (left to right): Kimberly Chappell, Valerie Dodane, Michael McGuire
Back Row (left to right): Mark Peters, Ronald Miller, Karen Cohen, Nabomita Hore
Not Pictured: Ross A. Baker, Jaime Bunn, Lynn Eagle, Samantha Gothelf, Marlene Holland, Laureen MacEachern,
Stella Nam, Kim Nguyen, Nima Patel, Connie Pfeiffer, Christian Reboulleau, Rob Schneller, Anjali Shah
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 12
10/27/10 9:42 AM
application Process and
eligibility requirements
Please address all correspondence to:
Dr. Joseph A. Barone, Pharm.D., F.C.C.P.
Professor and Chair
Department of Pharmacy Practice
and Administration
Ernest Mario School of Pharmacy
Rutgers, The State University
of New Jersey
160 Frelinghuysen Road
Piscataway, NJ 08854-8020
[email protected]
Fellows for the Rutgers Pharmaceutical Industry Fellowship Program
are selected on a nationally-competitive basis. Candidates must have
completed a Doctor of Pharmacy degree from an ACPE accredited
institution before July 1 of the fellowship term.
Participation in the ASHP Midyear Clinical Meeting/PPS is strongly
encouraged, but not required. Interested individuals are invited to
electronically submit a letter of intent, a curriculum vitae, and three
letters of recommendation to: [email protected]
Application materials may be submitted as early as November 15.
All applicants should also electronically complete a Program Interest
Form at: http://pharmafellows.rutgers.edu
key Program features
The Rutgers Pharmaceutical Industry Fellowship Program FOSTERs the
growth and development of future pharmaceutical and biopharmaceutical
industry professionals through the following key program features:
family of Leading Companies–Partners include several of the
top 10 global pharmaceutical and biopharmaceutical companies.
outstanding Alumni Track Record–Over 500 alumni hold prominent
positions at more than 100 different companies.
strong Network–Nearly 90 Fellows each year develop valuable,
lasting connections with each other, alumni, preceptors and faculty.
the Pathway to Industry–Since 1984, the Rutgers program has been
nationally recognized, trusted, and proven as the pathway to industry
for pharmacists.
enhanced Career Path–Increasingly challenging assignments build depth
of experience and enhance the potential for an accelerated career path.
rigorous Academic Component–Rutgers affiliation provides academic
and professional development opportunities.
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 13
10/27/10 9:42 AM
2010 / 2011 Pharmaceutical
Industry Fellowship Program
FPO
© 2010 Bristol-Myers Squibb, Princeton, NJ 08543
Printed on paper containing 20% post-consumer waste.
Cert no. xx-xxx-xxxxxx
NOUS08UBPI16404 09/10
NOUS08UBPI16404_v4_2010_FellowsBrochure.indd 14
10/27/10 9:42 AM